Anil Ananthaneni
Shreveport, LANPI 1154932994
Payments from drug & device makers
Across 106 payments — averaging $30.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$540
- GSK$374
- Daiichi Sankyo Inc.$362
- AbbVie$266
- AstraZeneca$220
- Lilly USA, LLC$143
- plus $1K from 27 others
What the payments were for
- Speaking & faculty fees$1254%
- Food & beverage$2,41474%
- Education$41713%
- Other$2999%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 15 | $540 |
| GSK | 8 | $374 |
| Daiichi Sankyo Inc. | 13 | $362 |
| AbbVie | 6 | $266 |
| AstraZeneca(2 entities) | 6 | $220 |
| Lilly USA, LLC | 2 | $143 |
| Merck | 2 | $143 |
| Astellas Pharma US Inc | 7 | $139 |
| Acrotech Biopharma Inc. | 2 | $137 |
| E.r. Squibb & Sons, L.L.C. | 5 | $88 |
| Bayer | 4 | $83 |
| Pfizer | 4 | $66 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $65 |
| Eisai Inc. | 3 | $62 |
| Sanofi | 3 | $59 |
| Beone Medicines USA, Inc. | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Recordati_rare_diseases_inc. | 2 | $47 |
| Incyte Corporation | 2 | $43 |
| Genentech USA, Inc. | 2 | $38 |
| Tersera Therapeutics LLC | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Seagen Inc. | 2 | $27 |
| Exelixis Inc. | 1 | $24 |
| Geron Corporation | 1 | $21 |
| Tempus AI, Inc | 1 | $20 |
| Bristol Myers Squibb | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| AVEO Pharmaceuticals, Inc. | 1 | $18 |
| Genmab U.S., Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $14 |
| Sobi, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abiraterone Acetate | 13 | $8,310 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $674 |
| Morphine Sulfate ErMorphine Sulfate | 17 | $415 |
| Dexamethasone | 13 | $267 |
| Oxycodone Hcl | 15 | $258 |
| Anastrozole | 11 | $252 |
| Gabapentin | 11 | $82 |
| Tamsulosin Hcl | 12 | $48 |
| Prednisone | 12 | $47 |
| Amlodipine Besylate | 13 | $29 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.